22nd North American ISSX Meeting – Montréal, Canada (15th-19th July)

Dr Colin Brown will be attending the 22nd North American Meeting of the International Society for the Study of Xenobiotics between 15 – 19 July 2018 in Montréal, Québec, Canada.

The meeting brings together individuals who are working on drug/xenobiotic research across a diverse range of fields such as clinical pharmacology and therapeutics, toxicology, oncology, endocrinology, physiology, biochemistry, medicinal chemistry, molecular and structural biology and genetics.

Two posters will be available for viewing between 16th-18th July in the Exhibition Hall. This will form part of the 2nd poster session on Tuesday 17th July from 12-2pm:  

Characterization of Cisplatin Toxicity in aProximateTM Human Proximal Tubule Cell Monolayers

Development of a Novel Predictive In Vitro Non-Human Primate Proximal Tubule Model for Drug Transporter and Nephrotoxicity Studies

Information of the aProximateTM assay will also be available throughout the meeting on the Solvo Biotechnology stand (Booth 210)

If you are attending the 22nd North American ISSX Meeting and would like to arrange a meeting with Dr Brown, to learn more about our product and services, then please let us know – https://newcellsbiotech.co.uk/collaborate

You might also be interested in…
New Statements

Newcells Biotech acquires IP for Retinal Organoids from Newcastle University

Newcells Biotech  is pleased to announce the acquisition of intellectual property pertaining to the methodology for the differentiation of three-dimensional retinal organoids from human induced pluripotent stem cells (hiPSCs) from Newcastle University.  The acquired technology will add to the growing portfolio of proprietary technologies that Newcells